Safe commodity assessments for OIE listed aquatic animal diseases

Safe commodity assessments
for OIE listed aquatic
animal diseases

All OIE (World Organisation for Animal Health) publications are protected by international copyright
law. Extracts may be copied, reproduced, translated, adapted or published in journals, documents,
books, electronic media and any other medium destined for the public, for information, educational or
commercial purposes, provided prior written permission has been granted by the OIE.
The designations and denominations employed and the presentation of the material in this publication
do not imply the expression of any opinion whatsoever on the part of the OIE concerning the legal
status of any country, territory, city or area or of its authorities, or concerning the delimitation of its
frontiers and boundaries.
The views expressed in signed articles are solely the responsibility of the authors. The mention of
specific companies or products of manufacturers, whether or not these have been patented, does not
imply that these have been endorsed or recommended by the OIE in preference to others of a similar
nature that are not mentioned.
© Copyright OIE, 2016
World Organisation for Animal Health
12, rue de Prony, 75017 Paris, France
Tel.: [phone]
Fax: [phone]
www.oie.int
ISBN: 978-92-95108-22-6

Assessments of the safety of aquatic animal commodities 3
Contents
Introduction......................................................................................................................................... 7
Chapter I: Assessments for OIE listed diseases of amphibians...................................................... 9
1. Aquatic animal product assessments for infection with Batrachochytrium dendrobatidis............... 9
A. Assessments using criteria in Article 5.4.1. (for Article 8.1.3. point 1) ....................................... 9
B. Assessments using criteria in Article 5.4.2. (for Article 8.1.12. point 1).................................... 17
2. Aquatic animal product assessments for infection with ranavirus................................................. 19
A. Assessments using criteria in Article 5.4.1. (for Article 8.2.3. point 1)...................................... 19
B. Assessments using criteria in Article 5.3.2. (for Article 8.2.12. point 1).................................... 27
Chapter II: Assessments for OIE listed diseases of crustaceans.................................................. 31
1. Aquatic animal product assessments for crayfish plague ............................................................. 31
A. Assessments using criteria in Article 5.41. (for Article 9.1.3. point 1)....................................... 31
B. Assessments using criteria in Article 5.4.2. (for Article 9.1.11. point 1).................................... 39
2. Aquatic animal product assessments for infectious hypodermal and haematopoietic necrosis.... 40
A. Assessments using criteria in Article 5.4.1. (for Article 9.3.3. point 1)...................................... 40
B. Assessments using criteria in Article 5.4.2. (for Article 9.3.11. point 1).................................... 53
3. Aquatic animal product assessments for infectious myonecrosis virus ........................................ 55
A. Assessments using criteria in Article 5.4.1. (for Article 9.4.3. point 1)...................................... 55
B. Assessments using criteria in Article 5.4.2. (for Article 9.4.11. point 1).................................... 64
4. Aquatic animal product assessments for necrotising hepatopancreatitis...................................... 66
A. Assessments using criteria in Article 5.4.1. (for Article 9.5.3. point 1)...................................... 66
B. Assessments using criteria in Article 5.4.2. (for Article 9.5.11. point 1).................................... 75
5. Aquatic animal product assessments for Taura syndrome ........................................................... 77
A. Assessments using criteria in Article 5.4.1. (for Article 9.6.3. point 1)...................................... 77
B. Assessments using criteria in Article 5.4.2. (for Article 9.6.11. point 1).................................... 84
6. Aquatic animal product assessments for white spot disease........................................................ 86
A. Assessments using criteria in Art. 5.4.1. (for Art. 9.7.3. point 1)............................................... 86
B. Assessments using criteria in Article 5.4.2. (for Article 9.7.11. point 1).................................... 93

Contents
4 Assessments of the safety of aquatic animal commodities
7. Aquatic animal product assessments for white tail disease ......................................................... 95
A. Assessments using Criteria in Art. 5.4.1. (for Article.9.8.3. point 1).......................................... 95
B. Assessments using Criteria in Article 5.4.2. (for Article 9.8.11. point 1) .................................102
8. Aquatic animal product assessments for infection with yellow head virus .................................. 104
A. Assessments using criteria in Article 5.4.1. (for Article 9.2.3. point 1).................................... 104
B. Assessments using criteria in Article 5.4.2. (for Article 9.2.11. point 1).................................. 111
Chapter III: Assessments for OIE listed diseases of molluscs ................................................... 113
1. Aquatic animal product assessments for infection with abalone herpesvirus ............................. 113
A. Assessments using Criteria in Article 5.4.1. (for Article 11.1.3. point 1) .................................113
B. Assessments using Criteria in Article 5.4.2. (for Article 11.1.11. point 1) ............................... 117
2. Aquatic animal product assessments for Infection with Bonamia exitiosa .................................. 118
A. Assessments using criteria in Article 5.4.1. (for Article 11.2.3. point 1).................................. 118
B. Assessments using criteria in Article 5.4.2. (for Article 11.2.11. point 1)................................ 123
3. Aquatic animal product assessments for infection with Bonamia ostreae................................... 124
A. Assessments using criteria in Article 5.4.1 (for Article 11.3.3. point 1)................................... 124
B. Assessments using criteria in Article 5.4.2. (for Article 11.3.11. point 1) ................................ 127
4. Aquatic animal product assessments for infection with Marteilia refringens ............................... 128
A. Assessments using criteria in Article 5.4.1. (for Article 11.4.3. point 1).................................. 128
B. Assessments using criteria in Article 5.4.2. (for Article 11.4.11. point 1) ................................ 131
5. Aquatic animal product assessments for infection with Perkinsus marinus ................................ 132
A. Assessments using criteria in Article 5.3.1. (for Article 11.5.3. point 1).................................. 132
B. Assessments using criteria in Article 5.4.2. (for Article 11.5.11. point 1) ................................ 134
6. Aquatic animal product assessments for infection with Perkinsus olseni.................................... 135
A. Assessments using criteria in Article 5.4.1. (for Article 11.6.3. point 1) .................................. 135
B. Assessments using criteria in Article 5.4.2. (for Article 11.6.11. point 1)................................ 137
7. Aquatic animal product assessments for infection with Xenohaliotis californiensis .................... 138
A. Assessments using criteria in Article 5.4.1. (for Article 11.7.3. point 1).................................. 138
B. Assessments using criteria in Article 5.4.2. (for Article 11.7.11. point 1) ................................ 141

Contents
Assessments of the safety of aquatic animal commodities 5
Chapter IV: Assessments for OIE listed diseases of fish ............................................................. 143
1. Aquatic animal product assessments for epizootic haematopoietic necrosis ............................. 143
A. Assessments using criteria in Article 5.4.1. (for Article 10.1.3. point 1).................................. 143
B. Assessments criteria in Article 5.4.2. (for Article 10.1.11. point 1) ......................................... 149
2. Aquatic animal product assessments for infection with Aphanomyces invadans (epizootic
ulcerative syndrome)................................................................................................................... 151
A. Assessments using criteria in Article 5.4.1. (for Article 10.2.3. point 1).................................. 151
B. Assessments criteria in Article 5.4.2. (for Article 10.2.11. point 1) ......................................... 160
3. Aquatic animal product assessments for infection with Gyrodactylus salaris ............................. 162
A. Assessments using criteria in Article 5.4.1. (for Article 10.3.3. point 1).................................. 162
B. Assessments using criteria in Article 5.4.2. (for Article 10.3.11. point 1)................................ 178
4. Aquatic animal product assessments for infectious haematopoietic necrosis virus.................... 180
A. Assessments using criteria in Article 5.4.1. (for Article 10.6.3. point 1).................................. 180
B. Assessments using criteria in Article 5.4.2. (for Article 10.6.11. point 1)................................ 191
5. Aquatic animal product assessments for infection with infectious salmon anaemia virus .......... 194
A. Assessments using criteria in Article 5.4.1. (for Article 10.4.3. point 1).................................. 194
B. Assessments using criteria in Article 5.4.2. (for Article 10.4.15. point 1)................................ 205
6. Aquatic animal product assessments for Koi herpesvirus disease ............................................. 208
A. Assessments using criteria in Article 5.4.1. (for Article 10.7.3. point 1).................................. 208
B. Assessments for criteria in Article 5.4.2. (for Article 10.7.11. point 1) .................................... 218
7. Aquatic animal product assessments for red sea bream iridovirus............................................. 221
A. Assessments using Criteria in Article 5.4.1. (for Article 10.8.3. point 1) .................................221
B. Assessments using Criteria in Article 5.4.2. (for Article 10.8.11. point 1) ............................... 227
8. Aquatic animal product assessments for spring viraemia of carp............................................... 229
A. Assessments using criteria in Article 5.4.1. (for Article 10.9.3. point 1).................................. 229
B. Assessments using criteria in Article 5.4.2. (for Article 10.9.11. point 1)................................ 235
9. Aquatic animal product assessments for viral haemorrhagic septicaemia virus......................... 237
A. Assessments using criteria in Article 5.4.1. (for Article 10.10.3. point 1)................................ 237
B. Assessments using Criteria in Article 5.4.2. (for Article 10.10.11. point 1) ............................. 249